Clinical practice examination: Experience with discents at the health area in Brazil

Author(s):  
Simone Yuriko Kameo ◽  
Glebson Moura Silva ◽  
Namie Okino Sawada ◽  
Bruno Ferreira Amorim ◽  
Jessica Santos Costa ◽  
...  
2021 ◽  
Vol 11 (5) ◽  
pp. 194
Author(s):  
Wen-Ho Chuo ◽  
Chun-Yann Lee ◽  
Tzong-Song Wang ◽  
Po-Sen Huang ◽  
Hsin-Hsin Lin ◽  
...  

With the wide application of the OSCE in the field of pharmacy, the development of e-assessment in OSCE is a predictable trend. However, the feasibility of its practical application and the acceptance of examiners who are accustomed to using traditional paper-based methods are worthy of being discussed. The e-assessment system (EAS) was constructed in this study and used in the examination process. Examiner satisfaction and changes in acceptance of EAS were evaluated. Examiners showed high recognition for the advantages of EAS in data processing, but EAS obviously made the examiner more nervous than the paper-based method. After repeated use of the e-OSCE system, the examiner’s satisfaction and acceptance significantly improved, which showed that there was a certain correlation between examiner’s familiarity with the assessment method and their acceptance. Besides, EAS has great advantages over traditional paper-based methods, and it is feasible in clinical practice examination of pharmacy education.


2018 ◽  
Vol 39 (1) ◽  
pp. 23 ◽  
Author(s):  
Kyong-Min Park ◽  
Kye-Yeung Park ◽  
Nam-Eun Kim ◽  
Bong-Kyung Seo ◽  
Hoon-Ki Park ◽  
...  

2018 ◽  
Vol 39 (2) ◽  
pp. 96
Author(s):  
Nam Eun Kim ◽  
Hoon Ki Park ◽  
Kyong Min Park ◽  
Bong Kyung Seo ◽  
Kye Yeung Park ◽  
...  

2020 ◽  
Vol 48 (5) ◽  
pp. 2295-2305
Author(s):  
Jiawei Zhang ◽  
Dandan Li ◽  
Rui Zhang ◽  
Peng Gao ◽  
Rongxue Peng ◽  
...  

The role of miR-21 in the pathogenesis of various liver diseases, together with the possibility of detecting microRNA in the circulation, makes miR-21 a potential biomarker for noninvasive detection. In this review, we summarize the potential utility of extracellular miR-21 in the clinical management of hepatic disease patients and compared it with the current clinical practice. MiR-21 shows screening and prognostic value for liver cancer. In liver cirrhosis, miR-21 may serve as a biomarker for the differentiating diagnosis and prognosis. MiR-21 is also a potential biomarker for the severity of hepatitis. We elucidate the disease condition under which miR-21 testing can reach the expected performance. Though miR-21 is a key regulator of liver diseases, microRNAs coordinate with each other in the complex regulatory network. As a result, the performance of miR-21 is better when combined with other microRNAs or classical biomarkers under certain clinical circumstances.


Sign in / Sign up

Export Citation Format

Share Document